Clover Health To Participate In Upcoming 2024 Keybanc Technology Leadership Forum And Canaccord Genuity 44Th Annual Growth Conference
Date
7/24/2024 4:17:17 PM
(MENAFN- GlobeNewsWire - Nasdaq) FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover health Investments, Corp. (Nasdaq: CLOV) (“Clover,”“Clover Health” or the“Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences:
CFO, Peter Kuipers, will participate in a fireside chat presentation at the 2024 KeyBanc Technology Leadership Forum on Tuesday, August 6, 2024, at 3:00 p.m. Eastern Time. CEO, Andrew Toy, and CFO, Peter Kuipers, will participate in a fireside chat presentation at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, 2024, at 2:00 p.m. Eastern Time.
A live webcast and reply of the fireside chat presentations will be accessible from Clover Health's investor relations website at .
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology's impact on Medication Adherence , as well as the earlier identification and management of Diabetes and Chronic Kidney Disease .
Press Contact:
Andrew Still-Baxter
...
Investor Relations Contact:
Ryan Schmidt
...
MENAFN24072024004107003653ID1108479256
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.